Tirzepatide-Induced Injection Site Reaction

被引：4
|
作者：
Mizumoto, Junki [1 ]
机构：
[1] Univ Tokyo, Int Res Ctr Med Educ, Grad Sch Med, Dept Med Educ Studies, Tokyo, Japan
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 09期
关键词：
tirzepatide; rash; glucagon-like peptide-1 receptor agonist; diabetes mellitus; adverse drug reaction;
D O I：
10.7759/cureus.45181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A male in his 70s developed a rash on his lower abdomen after changing his subcutaneous injection drug from dulaglutide to tirzepatide. The rash diminished after stopping tirzepatide injection. This case illustrated that tirzepatide can potentially lead to an injection site rash, despite another glucagon-like peptide-1 (GLP-1) receptor agonist (RA) being used without adverse reactions. Injection site reactions are one of the potential adverse events associated with GLP-1 RA use. To the best of our knowledge, this is the first reported case of tirzepatide-induced injection site reaction.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Abatacept/etanerceptLocal injection site pain, injection site reaction and infections: 2 case reports
    Reactions Weekly, 2021, 1884 (1) : 14 - 14
  • [22] Highly Frequent and Enhanced Injection Site Reaction Induced by Peripheral Venous Injection of Fosaprepitant in Anthracycline-Treated Patients
    Sato, Yumiko
    Kondo, Masahiro
    Inagaki, Atsushi
    Komatsu, Hirokazu
    Okada, Chika
    Naruse, Kumi
    Sahashi, Tomoyo
    Kuroda, Junko
    Ogura, Hiroka
    Uegaki, Shiori
    Yoshida, Tatsuya
    Mori, Yoshinori
    Sawada, Hiroo
    Watanabe, Shoichi
    Sugiura, Hiroshi
    Endo, Yumi
    Yoshimoto, Nobuyasu
    Toyama, Tatsuya
    Iida, Shinsuke
    Yamada, Koichi
    Kimura, Kazunori
    Wakita, Atsushi
    JOURNAL OF CANCER, 2014, 5 (05): : 390 - 397
  • [23] Injection-Site Reaction Following 5-Azacitidine Injection
    Jun, Hee Jin
    Ko, Hye Rim
    Lee, Jun Young
    Lee, Yung Bok
    Kim, Jin Woo
    Yu, Dong Soo
    ANNALS OF DERMATOLOGY, 2014, 26 (05) : 669 - 670
  • [24] Retrospective analysis of risk factor of injection site reaction induced by infusion of cisplatin plus vinorelbine
    Ozawa, N.
    Hase, T.
    Hatta, T.
    Sagara, A.
    Ichikawa, K.
    Miyazaki, M.
    Ando, M.
    Yamada, K.
    Hasegawa, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [25] Adalimumab/infliximabInfusion reaction and injection site reaction: 2 case reports
    Reactions Weekly, 2017, 1636 (1) : 15 - 15
  • [26] Highly frequent and serious cases of injection site reaction induced by peripheral venous injection of fosaprepitant in anthracycline-treated patients
    Sato, Y.
    Kondo, M.
    Inagaki, A.
    Komatsu, H.
    Okada, C.
    Sahashi, T.
    Kuroda, J.
    Kimura, T.
    Yamada, K.
    Wakita, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S392 - S392
  • [27] Uncommon local reaction at the injection site of subcutaneous methotrexate
    Fusta, Xavier
    Combalia, Andrea
    Guanabens, Nuria
    Iranzo, Pilar
    RHEUMATOLOGY, 2018, 57 (01) : 27 - 27
  • [28] Reaction at site of injection of mercurial diuretics as influenced by theophylline
    de Graff, AC
    Batterman, RC
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1935, 32 (09): : 1546 - 1548
  • [29] Bullous pemphigoid as an injection site reaction of glatiramer acetate
    Baghbanian, Seyed Mohammad
    Ghasemi, Maryam
    Sheidaei, Somayeh
    Hajheydari, Zohreh
    IRANIAN JOURNAL OF NEUROLOGY, 2019, 18 (04) : 187 - 189
  • [30] Severe, delayed insulin detemir injection site reaction
    Blumer, Ian
    DIABETIC MEDICINE, 2008, 25 (08) : 1008 - 1008
12345